Analyst Consensus
- Current Price
- 256.88 $
- Target (Low)
- 239.00 $
- Target (Mean)
- 291.73 $
- Target (High)
- 330.00 $
- Recommendation
- Buy
- Number of Analysts
- 22
Recommendation Distribution
Recommendation Distribution| Strong Buy | 2 |
|---|
| Buy | 13 |
|---|
| Hold | 7 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 29.2%
- Operating Margin
- 40.4%
- Gross Margin
- 56.5%
- Return on Equity (ROE)
- 40.7%
- Return on Assets (ROA)
- 9.1%
- Revenue Growth
- 3.2%
- Earnings Growth
- 6.2%
- Debt/Equity
- 162.25
- Current Ratio
- 0.92
- Beta
- 0.97
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Apr 24, 2026 | UBS | Neutral → Neutral |
| Apr 24, 2026 | Citigroup | Buy → Buy |
| Apr 24, 2026 | Barclays | Overweight → Overweight |
| Apr 24, 2026 | JP Morgan | Neutral → Neutral |
| Apr 24, 2026 | TD Cowen | Buy → Buy |
| Apr 24, 2026 | Benchmark | Buy → Buy |